Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation
21.85 +0.94 (4.50%)
20.38 +0.00%
- Marktkapitalisierung
- $1.16B
- Volumen
- 345K
- Nächster Ergebnistermin
- Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT) Aktienkurs, Analyse & Daten
Innerer Wert
Analystenprognose
Aktienprognosen →Letzte Ergebnisse
| Gemeldet | Vs. Schätzung | YoY-Veränderung | |
|---|---|---|---|
| Umsatz | $94.50M | n/a | +19.34% |
| EPS | -$0,47 | -$0,02 | -34.29% |
Kennzahlen
- Geld
- 13.9
- Marktkapitalisierung
- 1.16B
- Umsatz (TTM)
- 337M
- Nettogewinn (TTM)
- -110M
- 0.90
- -1.95
- n/a
- -17.68
- KBV (TTM)
- 3.43
- KUV (TTM)
- 3.46
- Termin Quartalszahlen
- Nov 4, 2026
- Brief
- 22.04
- Volumen
- 345,314
- Ø Vol. (20D)
- 1,578,080
- Eröffnung
- 20.86
- Vortagesschluss
- 20.91
- Tagesspanne
- 20.80 - 22.00
- 52-Wk Range
- 16.66 - 41.51
- Analyst
- n/a
- Kursziel
- n/a
- Dividenden
- n/a
- Ex-Dividenden-Datum
- n/a
Über PROCEPT BioRobotics Corporation
Profil ansehen →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Branche Medical Devices
Sektor Healthcare
IPO Datum Sep 15, 2021
Mitarbeiter 888
Börse NasdaqGM
Tickersymbol PRCT